The FDA Approves A New Drug, Vitrakvi, In Efforts To Beat Cancer – A Milestone In The Use Of Genetic Biomarkers
A cutting-edge cancer treatment which is focusing on genetic biomarkers eventually won accelerated approval from the FDA. Vitrakvi is the…